Suven Pharmaceuticals Ltd. Financial Overview
Suven Pharmaceuticals Ltd.'s market cap is currently ₹205.88B. The company's EPS TTM is ₹1.92; its P/E ratio is 64.66; Suven Pharmaceuticals Ltd. is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is ₹3.49. See an overview of income statement, balance sheet, and cash flow financials.
